Ibuprofen removal by a microfiltration membrane bioreactor during the startup phase.
MBR
aerobic bioreactor
anoxic bioreactor
ibuprofen
startup
Journal
Journal of environmental science and health. Part A, Toxic/hazardous substances & environmental engineering
ISSN: 1532-4117
Titre abrégé: J Environ Sci Health A Tox Hazard Subst Environ Eng
Pays: England
ID NLM: 9812551
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
4
12
2019
medline:
16
5
2020
entrez:
4
12
2019
Statut:
ppublish
Résumé
The behavior of ibuprofen (IBU) during the startup phase of a microfiltration membrane bioreactor (MBR) was determined. A full-scale experimental installation treating real urban wastewater was used for the study. The MBR was composed of an anoxic and an aerobic bioreactors working in pre-denitrification configuration, followed of a membrane reactor. A full mass balance was carried out to estimate the contribution of biotransformation and sorption to biomass to the overall removal of the IBU. During the startup phase of the MBR system there were significant oscillations of the operational variables, mainly of the sludge retention time (SRT); nevertheless, the capacity of the system for IBU removal was very high, with yields of over 94%, despite reaching minimum SRT values of 4.15 d. The main IBU removal occurs in the aerobic reactor, both in the liquid phase and the one associated with the sludge, while in the anoxic bioreactor the removal was scarce, although a certain transfer of IBU from the liquid phase to the sludge took place under anoxic conditions. Despite the high IBU removal yields during startup, the SRT was the most influential variable in IBU removal, an effect observed in all bioreactors, particularly in the anoxic one.
Identifiants
pubmed: 31793382
doi: 10.1080/10934529.2019.1697587
doi:
Substances chimiques
Membranes, Artificial
0
Sewage
0
Waste Water
0
Water Pollutants, Chemical
0
Ibuprofen
WK2XYI10QM
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM